In the tumor epithelium 14.8% of CD3+CD8+ T cells expressed the proliferating marker Ki67 compared to 33.7% of CD3+CD8-FoxP3- T cells (Figure 2A and Supplementary Table S4). This evidence concerns the gene FOXP3 and neoplasm.